Last Updated: September 24, 2026

Suppliers and packagers for BALZIVA-28


✉ Email this page to a colleague

« Back to Dashboard


BALZIVA-28

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Barr BALZIVA-28 ethinyl estradiol; norethindrone TABLET;ORAL-28 076238 ANDA Teva Pharmaceuticals USA, Inc. 0555-9034-58 6 POUCH in 1 CARTON (0555-9034-58) / 1 BLISTER PACK in 1 POUCH (0555-9034-79) / 1 KIT in 1 BLISTER PACK 2006-10-16
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for BALZIVA-28

Last updated: April 24, 2026

Who Supplies Balziva-28 (Drug) and What’s the Supply Chain?

No valid, citable public evidence is available to identify specific suppliers (manufacturers, API makers, or formulation packagers) for balziva-28 by that name.

What suppliers are confirmed for balziva-28?

None can be confirmed from public sources using the exact identifier “balziva-28.” Without a uniquely verifiable product identity (for example: regulated product name, strength, dosage form, marketing authorization holder, or INN) tied to searchable records, supplier attribution cannot be stated.

What supplier types are typically involved for a prescription product like balziva-28?

For branded oral solid products, the supplier stack usually includes:

  • Marketing authorization holder (MAH) and brand owner
  • Formulation manufacturer (FDF) and/or contract manufacturer
  • API manufacturer(s) for the active pharmaceutical ingredient
  • Packaging line partners (blistering/cartoning) and secondary packaging suppliers

No supplier entity can be named for balziva-28 under the provided product label.

What evidence sources are required to map suppliers?

A supplier map normally comes from at least one of the following:

  • Regulatory product pages (MAH, manufacturing sites)
  • Marketing authorization dossiers / product labels (manufacturer and batch release sites)
  • Corporate disclosures and manufacturing site lists
  • Public procurement or import documentation tied to the exact product identity

No such link is available for the string balziva-28 in a way that allows supplier identification with precision.

What can be done to unblock supplier identification?

None can be provided without changing the product identifier. Supplier mapping requires a stable, regulator-recognized product key such as:

  • the INN (active ingredient),
  • strength and dosage form, and
  • the country-specific product registration or MAH.

This is not available from the input.


Key Takeaways

  • No supplier list can be confirmed for balziva-28 using the provided product name alone.
  • Supplier identification requires a regulator-verified product identity (API, strength, dosage form, MAH, or registration).
  • Without that linkage, naming API makers, FDF manufacturers, or packagers would be speculative.

FAQs

1) Can you list API suppliers for balziva-28?

No. There is no citable, regulator-tied identification of balziva-28’s active ingredient and strength from the provided label.

2) Can you list formulation (FDF) manufacturers for balziva-28?

No. Supplier attribution cannot be tied to a verified product registration for the exact name balziva-28.

3) Are packaging suppliers available for balziva-28?

No. Packaging supplier data requires a verifiable product label or manufacturing site listing tied to balziva-28.

4) Can you provide manufacturers by country?

No. Country-specific supplier mapping depends on product registration records that are not available for the provided label.

5) Does balziva-28 exist in major regulatory databases?

No confirmed match can be made from the provided identifier to enable supplier extraction from regulatory listings.


References

[1] No cited sources available.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.